SLC6A3 and brain infarction: Dopamine (DA)-ergic pathway function is known to be greatly impaired in the weeks following brain infarction, as shown by decreased DA availability (Takagi et al., 1995), and both DRD2 (Gower and Tiberi, 2018) and DAT (Yanagisawa et al., 2006) expression.